📸 Photo Caption
Prof. Ali Pirayesh, founder of Amsterdam Plastic Surgery Clinic, Associate Professor at University College London, and board member of AMWC (Aesthetic & Anti-Aging Medicine World Congress), personally attended the NeoFilera product launch event to share the latest European clinical applications of collagen stimulators.
Photo provided by Diamond Biotechnology Co., Ltd.
Taiwan’s Aesthetic Medicine Industry Shines Globally as NeoFilera Launches New Innovation
Diamond Biotechnology Co., Ltd., a pioneer in Taiwan’s medical aesthetics industry, recently hosted a high-profile launch event for its cutting-edge brand, NeoFilera. The event attracted top professionals across academia, medicine, and industry, marking a significant step forward in aligning Taiwan’s aesthetic technologies with global standards.
The event was graced by Prof. Ali Pirayesh, a world-renowned expert in plastic and reconstructive surgery based in London. His presence brought international spotlight to the occasion, while his insights delivered a forward-looking perspective on the latest clinical trends in collagen stimulators across Europe.
Promoting Global Collaboration in Aesthetic Medicine
Prof. Ali Pirayesh is the founder of Amsterdam Plastic Surgery, Associate Professor at University College London, and a respected board member of the prestigious AMWC (Aesthetic & Anti-Aging Medicine World Congress). With decades of experience driving innovation in surgical aesthetics and international medical education, Dr. Pirayesh’s visit emphasized the growing synergy between Taiwan’s aesthetic market and global thought leadership.
During the event, he not only praised the professional excellence of Taiwan’s aesthetic practitioners but also shared invaluable insights on the clinical integration of collagen biostimulators in European markets, encouraging deeper dialogue and cross-border collaboration.
NeoFilera: Innovation Driving the Future of Aesthetic Treatment
NeoFilera introduces an advanced formulation that combines Poly-DL-lactic acid (PDLLA) with Carboxymethyl Cellulose (CMC), utilizing a proprietary double-emulsification process and wave-patterned microsphere structure to achieve uniform particle size and distribution.
The product is engineered for versatile and customizable applications, allowing medical professionals to adjust dosage and injection sites based on individual patient needs. This flexibility opens new frontiers for tailored aesthetic solutions and personalized treatment planning.
Globally Certified and Internationally Recognized
Since its launch, NeoFilera has received multiple international certifications and successfully entered markets such as Thailand, quickly becoming a rising star in the global aesthetic sector.
The product launch event not only underscored Taiwan’s strength in innovation but also captured the attention of global experts, reinforcing the island’s strategic importance in the evolving landscape of aesthetic medicine.
Acknowledging Industry Pillars and Charting a Global Path Forward
Special thanks go to Dr. Huang Chi-Chia, President of the Taiwan Academy of Aesthetic Medicine, and Prof. Chen Hsi-Ken, former President of the Taiwan Society of Plastic Surgery, for their unwavering support and foundational contributions to the local industry.
NeoFilera’s debut is just the beginning. Moving forward, the brand will remain committed to safety, innovation, and global integration, working alongside elite medical teams worldwide to propel Taiwan’s aesthetic medicine industry onto the international stage.
📸 Final Image Caption
NeoFilera: The flagship innovation from Diamond Biotechnology Co., Ltd.
An international breakthrough poised to redefine collagen-based aesthetic therapies.
